Acute and subacute toxicity evaluation of mega sanjeevi chooranam in rats
Bioinformation · 31.07.2026 · 22 (7) · 4438-4444
DOI: 10.6026/973206300224438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.07.2026. Verfasst von S. Iyswarya.
Abstract (Originalsprache)
Mega Sanjeevi Chooranam (MSC), a Siddha formulation indicated for Madhumegam (Diabetes mellitus), lacks validated safety data. Therefore, it is of interest to evaluate its preclinical safety in Wistar rats using acute and 28-day repeated oral toxicity models in accordance with OECD guidelines 423 and 407. MSC caused no mortality or treatment-related toxic effects up to 2000 mg/kg (acute) and 1800 mg/kg/day (subacute), with no significant alterations in clinical, hematological, biochemical, or histopathological parameters, confirming a favorable safety profile for further clinical evaluation.
Zitieren
APA
Iyswarya, S. (2026). Acute and subacute toxicity evaluation of mega sanjeevi chooranam in rats. Bioinformation, 22(7), 4438-4444. https://doi.org/10.6026/973206300224438
Vancouver
Iyswarya S. Acute and subacute toxicity evaluation of mega sanjeevi chooranam in rats. Bioinformation. 2026;22(7):4438-4444. doi:10.6026/973206300224438
BibTeX
@article{Iyswarya2026,
author = {Iyswarya, S.},
title = {Acute and subacute toxicity evaluation of mega sanjeevi chooranam in rats},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {7},
pages = {4438--4444},
doi = {10.6026/973206300224438}
}
EUVIMED